Stocks News

LAST PRICE
221.3700
TODAY'S CHANGE (%)
Trending Down-3.3800 (-1.5039%)

Bid / Lots
221.3400/ 1
Ask / Lots
221.5300/ 2
Open / Previous Close
225.2900 / 224.7500
Day Range
Low 220.9800
High 225.2900
52 Week Range
Low 161.6500
High 275.0000
Volume
245,121
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 13, 2024
- DJ Charles River Labs Is Maintained at Hold by TD Cowen, from 12:29PM ET on Monday May 13, 2024 by Dow Jones
  12:29PM ET on Monday May 13, 2024 by Dow Jones
  Companies Mentioned: CRL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 13, 2024 12:29 ET (16:29 GMT)
- TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260, from 6:55AM ET on Monday May 13, 2024 by MT Newswires
  6:55AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: CRL
  06:55 AM EDT, 05/13/2024 (MT Newswires) -- Charles River Laboratories International (CRL) has an average outperform rating and a price target range of $226 to $300, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity a...
May 10, 2024
- JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280, from 8:06AM ET on Friday May 10, 2024 by MT Newswires
  8:06AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: CRL
  08:06 AM EDT, 05/10/2024 (MT Newswires) -- Charles River Laboratories International (CRL) has an average rating of outperform and price targets ranging from $226 to $300, according to analysts polled by Capital IQ. (MT Newswires covers equity, commo...
- DJ Charles River Labs Is Maintained at Outperform by Baird, from 7:31AM ET on Friday May 10, 2024 by Dow Jones
  7:31AM ET on Friday May 10, 2024 by Dow Jones
  Companies Mentioned: CRL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 10, 2024 07:31 ET (11:31 GMT)
- Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235, from 7:22AM ET on Friday May 10, 2024 by MT Newswires
  7:22AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: CRL
  07:22 AM EDT, 05/10/2024 (MT Newswires) -- Charles River Laboratories International (CRL) has an average rating of outperform and price targets ranging from $226 to $300, according to analysts polled by Capital IQ. (MT Newswires covers equity, commo...

Today
- --Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: BMRN
Yesterday
- United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 18 hours ago by MT Newswires
  18 hours ago by MT Newswires
  Companies Mentioned: UTHR
May 14, 2024
- Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress, from 5:00PM ET on Tuesday May 14, 2024 by Business Wire
  5:00PM ET on Tuesday May 14, 2024 by Business Wire
  Companies Mentioned: INCY
- United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: UTHR
May 13, 2024
- Equities Close Mixed as Markets Weigh Consumer Inflation Survey, from 4:48PM ET on Monday May 13, 2024 by MT Newswires
  4:48PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: GME, INCY, PCAR, WBA
- Equities Close Mixed as Markets Parse Consumer Inflation Survey, from 4:30PM ET on Monday May 13, 2024 by MT Newswires
  4:30PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: INCY, PCAR, WBA
- Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing, from 4:14PM ET on Monday May 13, 2024 by MT Newswires
  4:14PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: BMRN
- Equities Mixed Intraday as Markets Analyze Consumer Inflation Survey, from 2:10PM ET on Monday May 13, 2024 by MT Newswires
  2:10PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: INCY, PCAR, WBA, FTRE
- Sector Update: Health Care Stocks Mixed in Afternoon Trading, from 1:49PM ET on Monday May 13, 2024 by MT Newswires
  1:49PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: INCY, WBA, FTRE
- Increasing Short-Term Inflation Expectations Weigh on US Equity Indexes Ahead of Consumer, Producer Prices, from 1:32PM ET on Monday May 13, 2024 by MT Newswires
  1:32PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: INCY, WBA

Charles River Laboratories International Inc
NYSE:CRLUnited States

Search Criteria

May 13, 2024

DJ Charles River Labs Is Maintained at Hold by TD Cowen, from 12:29PM ET on Monday May 13, 2024 by Dow Jones

TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260, from 6:55AM ET on Monday May 13, 2024 by MT Newswires

May 10, 2024

JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280, from 8:06AM ET on Friday May 10, 2024 by MT Newswires

DJ Charles River Labs Is Maintained at Outperform by Baird, from 7:31AM ET on Friday May 10, 2024 by Dow Jones

Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235, from 7:22AM ET on Friday May 10, 2024 by MT Newswires

Peers Headlines

Today

--Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 4 hours ago by MT Newswires

Yesterday

United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 18 hours ago by MT Newswires

May 14, 2024

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress, from 5:00PM ET on Tuesday May 14, 2024 by Business Wire

United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Equities Close Mixed as Markets Weigh Consumer Inflation Survey, from 4:48PM ET on Monday May 13, 2024 by MT Newswires

Equities Close Mixed as Markets Parse Consumer Inflation Survey, from 4:30PM ET on Monday May 13, 2024 by MT Newswires

Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing, from 4:14PM ET on Monday May 13, 2024 by MT Newswires

Equities Mixed Intraday as Markets Analyze Consumer Inflation Survey, from 2:10PM ET on Monday May 13, 2024 by MT Newswires

Sector Update: Health Care Stocks Mixed in Afternoon Trading, from 1:49PM ET on Monday May 13, 2024 by MT Newswires

Increasing Short-Term Inflation Expectations Weigh on US Equity Indexes Ahead of Consumer, Producer Prices, from 1:32PM ET on Monday May 13, 2024 by MT Newswires